Intrinsic value of Invacare - IVC

Previous Close

$6.03

  Intrinsic Value

$1.38

stock screener

  Rating & Target

str. sell

-77%

Previous close

$6.03

 
Intrinsic value

$1.38

 
Up/down potential

-77%

 
Rating

str. sell

We calculate the intrinsic value of IVC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.2

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  5.40
  5.36
  5.32
  5.29
  5.26
  5.24
  5.21
  5.19
  5.17
  5.15
  5.14
  5.13
  5.11
  5.10
  5.09
  5.08
  5.07
  5.07
  5.06
  5.05
  5.05
  5.04
  5.04
  5.04
  5.03
  5.03
  5.03
  5.02
  5.02
  5.02
Revenue, $m
  1,019
  1,073
  1,130
  1,190
  1,253
  1,318
  1,387
  1,459
  1,535
  1,614
  1,697
  1,784
  1,875
  1,971
  2,071
  2,176
  2,287
  2,402
  2,524
  2,652
  2,785
  2,926
  3,073
  3,228
  3,391
  3,561
  3,740
  3,928
  4,125
  4,332
Variable operating expenses, $m
  790
  830
  872
  916
  962
  1,010
  1,060
  1,113
  1,169
  1,227
  1,244
  1,308
  1,375
  1,445
  1,519
  1,596
  1,677
  1,762
  1,851
  1,945
  2,043
  2,146
  2,254
  2,367
  2,486
  2,612
  2,743
  2,881
  3,025
  3,177
Fixed operating expenses, $m
  267
  273
  279
  285
  291
  297
  304
  311
  317
  324
  332
  339
  346
  354
  362
  370
  378
  386
  395
  403
  412
  421
  431
  440
  450
  460
  470
  480
  491
  501
Total operating expenses, $m
  1,057
  1,103
  1,151
  1,201
  1,253
  1,307
  1,364
  1,424
  1,486
  1,551
  1,576
  1,647
  1,721
  1,799
  1,881
  1,966
  2,055
  2,148
  2,246
  2,348
  2,455
  2,567
  2,685
  2,807
  2,936
  3,072
  3,213
  3,361
  3,516
  3,678
Operating income, $m
  -38
  -30
  -20
  -11
  0
  11
  23
  35
  49
  63
  121
  137
  154
  171
  190
  211
  232
  254
  278
  304
  331
  359
  389
  421
  454
  490
  528
  567
  609
  654
EBITDA, $m
  15
  24
  34
  44
  55
  67
  80
  93
  107
  122
  137
  154
  172
  191
  211
  232
  254
  278
  303
  330
  358
  388
  419
  452
  488
  525
  564
  606
  650
  696
Interest expense (income), $m
  6
  28
  31
  36
  40
  44
  49
  54
  59
  65
  70
  76
  82
  89
  96
  103
  111
  119
  127
  136
  145
  154
  164
  175
  186
  198
  210
  223
  236
  250
  265
Earnings before tax, $m
  -66
  -61
  -56
  -50
  -44
  -38
  -31
  -24
  -16
  -8
  45
  54
  65
  76
  87
  100
  113
  128
  143
  159
  176
  195
  214
  235
  257
  280
  305
  331
  359
  389
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  12
  15
  17
  20
  24
  27
  31
  34
  39
  43
  48
  53
  58
  63
  69
  76
  82
  89
  97
  105
Net income, $m
  -66
  -61
  -56
  -50
  -44
  -38
  -31
  -24
  -16
  -8
  33
  40
  47
  55
  64
  73
  83
  93
  104
  116
  129
  142
  156
  171
  187
  204
  223
  242
  262
  284

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  1,124
  1,185
  1,248
  1,314
  1,383
  1,455
  1,531
  1,611
  1,694
  1,781
  1,873
  1,969
  2,069
  2,175
  2,286
  2,402
  2,524
  2,652
  2,786
  2,927
  3,074
  3,230
  3,392
  3,563
  3,742
  3,931
  4,128
  4,335
  4,553
  4,782
Adjusted assets (=assets-cash), $m
  1,124
  1,185
  1,248
  1,314
  1,383
  1,455
  1,531
  1,611
  1,694
  1,781
  1,873
  1,969
  2,069
  2,175
  2,286
  2,402
  2,524
  2,652
  2,786
  2,927
  3,074
  3,230
  3,392
  3,563
  3,742
  3,931
  4,128
  4,335
  4,553
  4,782
Revenue / Adjusted assets
  0.907
  0.905
  0.905
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
  0.906
Average production assets, $m
  298
  314
  331
  349
  367
  386
  406
  428
  450
  473
  497
  523
  549
  577
  607
  638
  670
  704
  740
  777
  816
  857
  901
  946
  993
  1,043
  1,096
  1,151
  1,209
  1,269
Working capital, $m
  68
  72
  76
  80
  84
  88
  93
  98
  103
  108
  114
  120
  126
  132
  139
  146
  153
  161
  169
  178
  187
  196
  206
  216
  227
  239
  251
  263
  276
  290
Total debt, $m
  279
  315
  353
  393
  435
  478
  524
  572
  622
  675
  730
  788
  849
  912
  979
  1,049
  1,123
  1,200
  1,281
  1,365
  1,455
  1,548
  1,646
  1,749
  1,857
  1,971
  2,090
  2,215
  2,346
  2,484
Total liabilities, $m
  678
  714
  752
  792
  834
  878
  923
  971
  1,021
  1,074
  1,129
  1,187
  1,248
  1,312
  1,378
  1,448
  1,522
  1,599
  1,680
  1,765
  1,854
  1,947
  2,046
  2,149
  2,257
  2,370
  2,489
  2,614
  2,746
  2,883
Total equity, $m
  446
  470
  495
  522
  549
  578
  608
  639
  672
  707
  744
  782
  822
  863
  907
  954
  1,002
  1,053
  1,106
  1,162
  1,221
  1,282
  1,347
  1,415
  1,486
  1,560
  1,639
  1,721
  1,808
  1,898
Total liabilities and equity, $m
  1,124
  1,184
  1,247
  1,314
  1,383
  1,456
  1,531
  1,610
  1,693
  1,781
  1,873
  1,969
  2,070
  2,175
  2,285
  2,402
  2,524
  2,652
  2,786
  2,927
  3,075
  3,229
  3,393
  3,564
  3,743
  3,930
  4,128
  4,335
  4,554
  4,781
Debt-to-equity ratio
  0.620
  0.670
  0.710
  0.750
  0.790
  0.830
  0.860
  0.890
  0.930
  0.950
  0.980
  1.010
  1.030
  1.060
  1.080
  1.100
  1.120
  1.140
  1.160
  1.180
  1.190
  1.210
  1.220
  1.240
  1.250
  1.260
  1.280
  1.290
  1.300
  1.310
Adjusted equity ratio
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397
  0.397

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -66
  -61
  -56
  -50
  -44
  -38
  -31
  -24
  -16
  -8
  33
  40
  47
  55
  64
  73
  83
  93
  104
  116
  129
  142
  156
  171
  187
  204
  223
  242
  262
  284
Depreciation, amort., depletion, $m
  53
  54
  54
  55
  55
  56
  57
  57
  58
  59
  17
  17
  18
  19
  20
  21
  22
  23
  25
  26
  27
  29
  30
  32
  33
  35
  37
  38
  40
  42
Funds from operations, $m
  -13
  -7
  -2
  4
  11
  18
  25
  34
  42
  51
  49
  57
  65
  74
  84
  94
  105
  117
  129
  142
  156
  171
  186
  203
  221
  239
  259
  280
  302
  326
Change in working capital, $m
  3
  4
  4
  4
  4
  4
  5
  5
  5
  5
  6
  6
  6
  6
  7
  7
  7
  8
  8
  9
  9
  9
  10
  10
  11
  11
  12
  13
  13
  14
Cash from operations, $m
  -16
  -11
  -6
  0
  7
  14
  21
  29
  37
  46
  44
  51
  59
  68
  77
  87
  98
  109
  121
  133
  147
  161
  176
  193
  210
  228
  247
  268
  289
  312
Maintenance CAPEX, $m
  -9
  -10
  -10
  -11
  -12
  -12
  -13
  -14
  -14
  -15
  -16
  -17
  -17
  -18
  -19
  -20
  -21
  -22
  -23
  -25
  -26
  -27
  -29
  -30
  -32
  -33
  -35
  -37
  -38
  -40
New CAPEX, $m
  -16
  -16
  -17
  -18
  -18
  -19
  -20
  -21
  -22
  -23
  -24
  -25
  -27
  -28
  -29
  -31
  -32
  -34
  -36
  -37
  -39
  -41
  -43
  -45
  -48
  -50
  -52
  -55
  -58
  -61
Cash from investing activities, $m
  -25
  -26
  -27
  -29
  -30
  -31
  -33
  -35
  -36
  -38
  -40
  -42
  -44
  -46
  -48
  -51
  -53
  -56
  -59
  -62
  -65
  -68
  -72
  -75
  -80
  -83
  -87
  -92
  -96
  -101
Free cash flow, $m
  -41
  -37
  -33
  -28
  -23
  -18
  -12
  -6
  1
  8
  4
  9
  15
  22
  29
  36
  44
  53
  62
  71
  82
  93
  105
  117
  131
  145
  160
  176
  193
  211
Issuance/(repayment) of debt, $m
  35
  36
  38
  40
  42
  44
  46
  48
  50
  53
  55
  58
  61
  64
  67
  70
  73
  77
  81
  85
  89
  94
  98
  103
  108
  113
  119
  125
  131
  138
Issuance/(repurchase) of shares, $m
  89
  85
  81
  77
  72
  67
  61
  55
  49
  42
  4
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  124
  121
  119
  117
  114
  111
  107
  103
  99
  95
  59
  58
  61
  64
  67
  70
  73
  77
  81
  85
  89
  94
  98
  103
  108
  113
  119
  125
  131
  138
Total cash flow (excl. dividends), $m
  83
  84
  86
  88
  90
  93
  95
  97
  100
  103
  62
  67
  76
  85
  95
  106
  118
  130
  143
  156
  171
  186
  203
  220
  239
  258
  279
  301
  324
  349
Retained Cash Flow (-), $m
  -89
  -85
  -81
  -77
  -72
  -67
  -61
  -55
  -49
  -42
  -36
  -38
  -40
  -42
  -44
  -46
  -48
  -51
  -53
  -56
  -59
  -62
  -65
  -68
  -71
  -75
  -78
  -82
  -86
  -91
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  -6
  -1
  5
  12
  18
  26
  34
  42
  51
  61
  26
  29
  36
  43
  51
  60
  69
  79
  89
  100
  112
  125
  138
  152
  167
  184
  201
  219
  238
  258
Discount rate, %
  6.20
  6.51
  6.84
  7.18
  7.54
  7.91
  8.31
  8.72
  9.16
  9.62
  10.10
  10.60
  11.13
  11.69
  12.28
  12.89
  13.53
  14.21
  14.92
  15.67
  16.45
  17.27
  18.14
  19.04
  20.00
  21.00
  22.05
  23.15
  24.30
  25.52
PV of cash for distribution, $m
  -5
  -1
  4
  9
  13
  16
  19
  21
  23
  24
  9
  9
  9
  9
  9
  9
  8
  7
  6
  5
  5
  4
  3
  2
  2
  1
  1
  1
  0
  0
Current shareholders' claim on cash, %
  76.9
  60.5
  48.5
  39.8
  33.2
  28.3
  24.6
  21.7
  19.6
  18.0
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8
  17.8

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company's geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services.

FINANCIAL RATIOS  of  Invacare (IVC)

Valuation Ratios
P/E Ratio -4.5
Price to Sales 0.2
Price to Book 0.5
Price to Tangible Book
Price to Cash Flow -3.4
Price to Free Cash Flow -2.9
Growth Rates
Sales Growth Rate -8.3%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 25%
Cap. Spend. - 3 Yr. Gr. Rate -6.5%
Financial Strength
Quick Ratio 8
Current Ratio 0
LT Debt to Equity 34.6%
Total Debt to Equity 38.2%
Interest Coverage -4
Management Effectiveness
Return On Assets -3.9%
Ret/ On Assets - 3 Yr. Avg. -3.7%
Return On Total Capital -7.9%
Ret/ On T. Cap. - 3 Yr. Avg. -7.1%
Return On Equity -9.7%
Return On Equity - 3 Yr. Avg. -7.9%
Asset Turnover 1.2
Profitability Ratios
Gross Margin 27.1%
Gross Margin - 3 Yr. Avg. 27.3%
EBITDA Margin -0.9%
EBITDA Margin - 3 Yr. Avg. -0.8%
Operating Margin -2.9%
Oper. Margin - 3 Yr. Avg. -3%
Pre-Tax Margin -2.9%
Pre-Tax Margin - 3 Yr. Avg. -3%
Net Profit Margin -4.1%
Net Profit Margin - 3 Yr. Avg. -3.6%
Effective Tax Rate -43.3%
Eff/ Tax Rate - 3 Yr. Avg. -56.5%
Payout Ratio -4.7%

IVC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the IVC stock intrinsic value calculation we used $966.497 million for the last fiscal year's total revenue generated by Invacare. The default revenue input number comes from 0001 income statement of Invacare. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our IVC stock valuation model: a) initial revenue growth rate of 5.4% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 6.2%, whose default value for IVC is calculated based on our internal credit rating of Invacare, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Invacare.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of IVC stock the variable cost ratio is equal to 77.8%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $261 million in the base year in the intrinsic value calculation for IVC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 11.3% for Invacare.

Corporate tax rate of 27% is the nominal tax rate for Invacare. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the IVC stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for IVC are equal to 29.3%.

Life of production assets of 33.4 years is the average useful life of capital assets used in Invacare operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for IVC is equal to 6.7%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $423.294 million for Invacare - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 33.23 million for Invacare is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Invacare at the current share price and the inputted number of shares is $0.2 billion.

RELATED COMPANIES Price Int.Val. Rating
HRC Hill-Rom Holdi 92.75 61.32  sell
SYK Stryker 168.72 100.38  sell
AHPI Allied Healthc 2.00 1.01  str.sell
INGN Inogen 139.01 92.74  str.sell
OMI Owens&Minor 8.86 114.18  str.buy

COMPANY NEWS

▶ Why Invacare Corporation Stock Collapsed on Tuesday   [Nov-07-18 07:16AM  Motley Fool]
▶ Invacare: 3Q Earnings Snapshot   [06:55PM  Associated Press]
▶ Moving Average Crossover Alert: Invacare (IVC)   [Sep-07-18 09:30AM  Zacks]
▶ Invacare Declares Quarterly Dividend   [Aug-30-18 03:35PM  Business Wire]
▶ KeyBanc: 3 Reasons Why Invacare Is No Longer A Buy   [Aug-16-18 10:04AM  Benzinga]
▶ Invacare Corporation to Host Earnings Call   [Aug-08-18 06:30AM  ACCESSWIRE]
▶ Invacare: 2Q Earnings Snapshot   [07:47PM  Associated Press]
▶ Invacare (IVC) Enters Oversold Territory   [May-24-18 07:39AM  Zacks]
▶ Invacare Declares Quarterly Dividend   [01:51PM  Business Wire]
▶ Invacare: 1Q Earnings Snapshot   [May-07-18 06:53PM  Associated Press]
▶ Invacare Appoints Kathleen Leneghan Chief Financial Officer   [Feb-22-18 06:19PM  Business Wire]
▶ Invacare Declares Quarterly Dividend   [11:20AM  Business Wire]
▶ Invacare reports 4Q loss   [05:01AM  Associated Press]
▶ Charles Brandes Sells Telecom Italia and Invacare Corp   [Feb-06-18 04:25PM  GuruFocus.com]
▶ Should You Buy Invacare Corporation (NYSE:IVC) Now?   [Dec-30-17 06:55AM  Simply Wall St.]
▶ ETFs with exposure to Invacare Corp. : December 12, 2017   [Dec-12-17 01:23PM  Capital Cube]
▶ ETFs with exposure to Invacare Corp. : November 27, 2017   [Nov-27-17 02:19PM  Capital Cube]
▶ Invacare Declares Quarterly Dividend   [Nov-16-17 10:40AM  Business Wire]
▶ Why Invacare Corporation Is Rising Today   [Nov-08-17 04:25PM  Motley Fool]
▶ Invacare reports 3Q loss   [Nov-07-17 07:40PM  Associated Press]
▶ Invacare Announces Departure of Chief Financial Officer   [Nov-02-17 04:30PM  Business Wire]
▶ ETFs with exposure to Invacare Corp. : August 25, 2017   [Aug-25-17 04:43PM  Capital Cube]
▶ Invacare Declares Quarterly Dividend   [09:24AM  Business Wire]
▶ Invacare reports 2Q loss   [Aug-07-17 11:33PM  Associated Press]
▶ Invacare Reaches New Consent Decree Milestone   [Jul-25-17 08:35AM  Business Wire]
▶ ETFs with exposure to Invacare Corp. : July 24, 2017   [Jul-24-17 04:47PM  Capital Cube]
▶ ETFs with exposure to Invacare Corp. : July 14, 2017   [Jul-14-17 03:08PM  Capital Cube]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.